Agilon Health, Inc. (NYSE:AGL – Get Free Report) traded down 8% during mid-day trading on Thursday . The company traded as low as $78.88 and last traded at $77.7950. Approximately 51,105 shares traded hands during trading, a decline of 85% from the average session volume of 335,643 shares. The stock had previously closed at $84.56.
Analyst Ratings Changes
AGL has been the topic of a number of recent analyst reports. Royal Bank Of Canada set a $125.00 price objective on Agilon Health in a report on Tuesday, September 15th. Citigroup upgraded shares of Agilon Health from a “sell” rating to a “neutral” rating and increased their price target for the company from $105.00 to $115.00 in a research note on Monday, August 10th. Weiss Ratings reissued a “sell (e+)” rating on shares of Agilon Health in a report on Monday, August 24th. Truist Financial set a $112.00 target price on shares of Agilon Health and gave the company a “hold” rating in a report on Thursday, August 6th. Finally, Sanford C. Bernstein raised shares of Agilon Health from a “market perform” rating to an “outperform” rating and increased their target price for the company from $86.00 to $125.00 in a research report on Tuesday, September 15th. Six investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Agilon Health currently has an average rating of “Hold” and an average price target of $102.25.
Check Out Our Latest Stock Analysis on AGL
Agilon Health Trading Down 13.3%
Agilon Health (NYSE:AGL – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. The firm had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. As a group, analysts expect that Agilon Health, Inc. will post -2.9 earnings per share for the current fiscal year.
Institutional Trading of Agilon Health
Several institutional investors and hedge funds have recently added to or reduced their stakes in AGL. Allworth Financial LP acquired a new stake in shares of Agilon Health in the second quarter worth $114,000. Proficio Capital Partners LLC acquired a new position in shares of Agilon Health during the 2nd quarter valued at $210,000. Bank of New York Mellon Corp boosted its position in Agilon Health by 9.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 35,336 shares of the company’s stock worth $3,787,000 after purchasing an additional 3,074 shares during the period. The Manufacturers Life Insurance Company acquired a new stake in Agilon Health in the 2nd quarter valued at $355,000. Finally, Integrated Wealth Concepts LLC acquired a new stake in Agilon Health in the 2nd quarter valued at $384,000.
Agilon Health Company Profile
Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company focuses primarily on patients enrolled in Medicare Advantage plans and works with physician groups to coordinate care, improve outcomes and manage healthcare costs.
Agilon provides physicians with technology, analytics, operational support and clinical resources designed to help them manage the health of defined patient populations.
Read More
- Five stocks we like better than Agilon Health
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
- Is Palantir Worth $250 or $1? Bulls and Burry Arrive at Opposite Conclusions
- 3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure Builds
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
